Medivir (NASDAQ OMX Stockholm) has carried out a directed new issue of shares for approximately SEK 280 million directed towards international institutional investors and qualified investors in Sweden. Vinge acted for Medivir.
Vinge’s team consisted of Erik Sjöman and Emil Hedberg.